Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03319225 · ClinicalTrials.gov registry record
Examining the Distal Gut Microbiome After Spinal Cord Injury
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 5
- Enrollment target
NCT03319225: Completed study, sponsored by University of Miami.
NCT03319225 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03319225 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about the causes of gastrointestinal dysfunction after spinal cord injury. It has been thought that the microbiome (the community of bacteria in the body) may be one such cause. The study will examine whether changes in the distal gut microbiome are related to gastrointestinal dysfunction in persons with Spinal Cord Injury and Non-Disabled Controls.
Primary Outcome
Characterize the distal gut microbiome within and across the three groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2018-01-09 |
What the finished NCT03319225 record still lists
NCT03319225 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03319225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03319225 about?
NCT03319225 is a clinical study titled "Examining the Distal Gut Microbiome After Spinal Cord Injury". The purpose of this research study is to learn more about the causes of gastrointestinal dysfunction after spinal cord injury. It has been thought that the microbiome (the community of bacteria in the body) may be one such cause. The study will examine whether changes in the distal gut microbiome ar...
What is the current status of trial NCT03319225?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2017-12-18. Estimated completion is 2018-01-09.
Who is sponsoring clinical trial NCT03319225?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI